Total Funding
75
84
Total FundingVenture - Series Unknown raised
Growth Score 75 in past quarter
-1 pts
Heat Score 84 in past quarter
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
13272
Rznomics is a biotechnology company focused on research and development of biopharmaceuticals, developing gene therapy drugs.
- Seongwook Lee: CEO & Founder
- Lim Jong-seon: CFO
About the Company
Rznomics Inc. is a South Korean biotechnology company developing RNA-based gene therapies for cancer, genetic, and neurodegenerative diseases. The company focuses on trans-splicing ribozyme and circular RNA technologies, with pipeline candidates targeting liver cancer, glioblastoma, Alzheimer’s disease, and retinal disorders.